Fig. 3: BCR-ABL affects the intrinsic apoptotic pathway through upregulation of prosurvival and downregulation of proapoptotic proteins.
Targeting of these protein results in a shift away from apoptosisin CML cells. Black arrows indicate BCR-ABL-mediated up- or downregulation.
